-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Golimumab Biosimilar in Inflammation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golimumab Biosimilar in Inflammation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Golimumab Biosimilar in Inflammation Drug Details:Monoclonal antibody is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (Febuxostat + Inosine) in Mitochondrial Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Febuxostat + Inosine) in Mitochondrial Diseases report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.(Febuxostat + Inosine) in Mitochondrial DiseasesDrug Details:A fixed dose combination of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Golimumab Biosimilar in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golimumab Biosimilar in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Golimumab Biosimilar in Rheumatoid ArthritisDrug Details:Monoclonal antibody is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Aflibercept Biosimilar in Wet (Neovascular / Exudative) Macular Degeneration
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aflibercept Biosimilar in Wet (Neovascular / Exudative) Macular Degeneration report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aflibercept Biosimilar in Wet (Neovascular /...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cellular Immunotherapy For Hematological Malignancy And Solid Tumor in Bladder Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Cellular Immunotherapy For Hematological Malignancy And Solid Tumor in Bladder Cancer Drug Details: Cellular therapy...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SFA-002 ER in Plaque Psoriasis (Psoriasis Vulgaris)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SFA-002 ER in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details: SFA-002 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nemonoxacin in Diabetic Foot Infection (DFI)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nemonoxacin in Diabetic Foot Infection (DFI) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nemonoxacin in Diabetic Foot Infection (DFI) Drug Details: Nemonoxacin (Taigexyn,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Serabelisib in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Serabelisib in Endometrial Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Serabelisib in Endometrial Cancer Drug Details:Serabelisib (TAK-117, INK1117) is under development for solid...
-
Sector Analysis
Mergers and Acquisitions (M&A) in the Contract Manufacturing Industry – Implications and Outlook – 2023 Edition
M and A In Pharmaceutical Contract Manufacturing Industry Report Overview During 2018–22, contract manufacturing organization (CMO) merger and acquisition (M&A) deal activity increased, and the targeted manufacturers have adopted specialized capabilities such as controlled substance and containment manufacture. Despite considerable macroeconomic challenges for pharma manufacturers, 2021–22 witnessed strong M&A activity and CMO valuations, although there was a slight decline in CMO M&A activity in 2022 due to rising inflation and interest rates. The Mergers and Acquisitions (M&A) in the Contract...
-
Product Insights
Psoriatic Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Psoriatic arthritis is a form of arthritis that affects some people who have psoriasis. Symptoms include swollen fingers and toes, foot pain, and lower back pain. Risk factors include age, family history, and psoriasis. Treatment includes NSAIDs, immunosuppressants, and surgery. The Psoriatic Arthritis pipeline drugs market research report provides comprehensive information on the therapeutics under development for Psoriatic Arthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The...